Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS1008 A&B Eff/Safety Trial of BUP/NX for the Treatment of Opiate Dependence
NCT00015171Phase 3Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Apr 1996
- Primary completion
- May 1997
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3 trial of buprenorphine and naloxone in opioid use disorder (OUD), sponsored by National Institute on Drug Abuse. Primary endpoints: Craving, Drug use and 3 more. Started Apr 1996; status: completed.
02
Drugs
buprenorphinenaloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00015171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00015171.